The Allograft product range is being produced with the approved ALLOTEC® procedure of the C+TBA; Maxgraft ortho is an approved pharmaceutical by the PaulEhrlichInstitut since July 28th 2015 ( ) The transplantat has a high biological quality; The application of allogeneic bone material is represented in the DRG system